SAN DIEGO, Dec. 11 /PRNewswire-FirstCall/ -- MediciNova, Inc., a specialty pharmaceutical company that is publicly traded on the NASDAQ Global Market and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), today announced that MediciNova will participate in the RBC Capital Markets Healthcare conference to be held on Wednesday December 13th and Thursday December 14th. The Conference is being held at the Westin New York at Times Square in New York City.
About MediciNova
MediciNova, Inc. is a publicly traded biopharmaceutical company focused on accelerating the global development and commercialization of innovative pharmaceutical products. MediciNova's pipeline, which includes six compounds in clinical testing, targets a variety of prevalent medical conditions, including asthma, multiple sclerosis, status asthmaticus, interstitial cystitis, cancer, Generalized Anxiety Disorder, preterm labor, urinary incontinence and thrombotic disorders. For more information on MediciNova, Inc., please visit www.medicinova.com.
MediciNova, Inc.CONTACT: Shintaro Asako, Vice-President Accounting and Administration ofMediciNova, Inc., +1-858-373-1500, asako@medicinova.com
Web site: http://www.medicinova.com/
